Clinical Trials Sponsored by Dickinson College

Total 10981 results

Becton, Dickinson and Company

Recruiting

Study of BD Pre-filled Flush Syringes in China

Effectiveness and Safety of Pre-filled Flush Syringe

China
Becton, Dickinson and Company

Recruiting

Evaluation of the BD OneFlow Acute Leukemia Panel on the BD FACSLyric Flow Cytometer

Acute Leukemia

United States, Spain, Brazil, Czechia, United Kingdom
Becton, Dickinson and Company

Completed

Evaluation of the Chronic Lymphoproliferative Diseases Limited Panel on the BD FACSLyric™ Flow Cytometer

Chronic Lymphoproliferative Diseases (CLPD)

United States, Switzerland, Spain, United Kingdom, Portugal
Becton, Dickinson and Company

Completed

The Role of Proper Insulin Injection Technique in the Treatment of Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Lipohypertrophy

Russian Federation
Becton, Dickinson and Company

Completed

Prospective Healthy Volunteer Study of the Securis™ Stabilization Device

Peripheral Intavenous Catheter Stabilization

United States
Becton, Dickinson and Company

Completed

A 7 Day Adhesive Device Wear Study to Evaluate BD StatLock™ Devices

Peripheral Intravenous Catheter Stabilization

United States
Becton, Dickinson and Company

Completed

Evaluation of the Antimicrobial Effectiveness of CHG/IPA

Microbial Colonization

Romania
Becton, Dickinson and Company

Completed

Effectiveness of an Antimicrobial Agent for Preoperative Skin Preparation

Preoperative Skin Preparation

United States
Becton, Dickinson and Company

Completed

Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens

Human Papillomavirus | Cervical Neoplasms

United States, Canada
Becton, Dickinson and Company

Completed

Comparative User Experiences With BD Nano™ PRO 4mm x 32G Extra Thin Wall Pen Needle vs Three Commercially Available Pen Needles

Diabetes

United States
Becton, Dickinson and Company

Completed

Clinical Evaluation of BD NEXT Pen Needle

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States, Canada
Becton, Dickinson and Company

Completed

Monitoring the Infusion Pressure in Insulin Infusion Sets in Healthy Adults

Diabetes

United States
Becton, Dickinson and Company

Completed

Accuracy Evaluation of the BD FACS Presto System

Acquired Immunodeficiency Syndrome

United States, India, Kenya, Thailand
Becton, Dickinson and Company

Completed

Study of Effectiveness of Smaller Gauge Fenestrated Catheters for Use in IV Contrast Enhanced CT Scans (ARCTR05)

Contrast Enhanced Computed Tomography

United States
Becton, Dickinson and Company

Completed

Pharmacokinetics/Dynamics of Basal (Continuous) Insulin Infusion Administered Either Intradermally or Subcutaneously

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Germany
Becton, Dickinson and Company

Completed

Evaluation of Blood Volume and Perceived Pain During Fingerstick Monitoring of Blood Glucose

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Becton, Dickinson and Company

Recruiting

BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

Chronic Lymphoproliferative Diseases (CLPD)

Switzerland, United States, Portugal, Spain
Becton, Dickinson and Company

Completed

BD Evolve™ On-body Injector's Adherence Performance - Wear Study

Healthy Volunteers

United States
Becton, Dickinson and Company

Completed

BD Veritor™ At-Home and BD Veritor™ Professional

Upper Respiratory Infection

New Zealand, Australia, United States
Becton, Dickinson and Company

Completed

A Clinical Trial Evaluating the Effectiveness and Safety of the PowerMe Midline Catheter in the Chinese Population

Catheterization

China
Becton, Dickinson and Company

Withdrawn

Capturing Infectious COVID-19 Asymptomatic Cases in Singapore

Covid19 | SARS CoV-2

Singapore
Becton, Dickinson and Company

Terminated

Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes

Diabetes Mellitus, Type 2

United States
Becton, Dickinson and Company

Completed

Comparative User Experiences With BD Nano™ PRO 32G Extra Thin Wall Pen Needle vs the Terumo Nanopass® 34G Pen Needle

Diabetes

United States
Becton, Dickinson and Company

Terminated

An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Belgium
Becton, Dickinson and Company

Completed

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Diabetes

United States
Becton, Dickinson and Company

Completed

A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces

Diabetes

United States
Becton, Dickinson and Company

Completed

Comparison of Glycemic Control in Obese Diabetics Using Three Different Pen Needles

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Becton, Dickinson and Company

Completed

European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System

Uterine Cervical Neoplasms

Italy, Denmark
Becton, Dickinson and Company

Completed

Multi-day (3) In-patient Evaluation of Intradermal Versus Subcutaneous Basal and Bolus Insulin Infusion

Diabetes

Germany
Becton, Dickinson and Company

Completed

Study on the Effects on Blood Glucose Following Intradermal and Subcutaneous Dosing of Insulin in Diabetic Patients

Diabetes

Germany
University of Pennsylvania
Pfizer; Pennsylvania Department of Health; Dickinson College

Completed

Collaboration to Reduce Disparities in Hypertension

Hypertension

United States
Becton, Dickinson and Company

Recruiting

Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories.

Analgesia | Anesthesia

Germany, Austria, Spain
Becton, Dickinson and Company

Active, not recruiting

Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit

Cervical Cancer

China
Becton, Dickinson and Company

Completed

Investigational On-body Injector Clinical Study

Healthy Volunteers

France
Becton, Dickinson and Company

Completed

Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer

Plasma Cell Disorder

Switzerland, Spain, United Kingdom, United States, Portugal
Becton, Dickinson and Company

Completed

An Observational Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors

Catheter Related Complication | Vascular Access Site Management | Disinfecting Cap

Belgium, Austria, Spain, Italy
Becton, Dickinson and Company

Terminated

Intended Use Study of the BD SurePath Plus™ Pap

Neoplasms | Neoplasms by Histologic Type | Neoplasms, Glandular and Epithelial | Uterine Cervical Neoplasms | Papilloma | Neoplasms, Squamous Cell | Uterine Cervical Cancer

United States
Becton, Dickinson and Company

Terminated

Evaluation of a 4mmx32G Pen Needle for Injection of Basal Insulin Doses Above 40 Units

Diabetes Mellitus, Type 2

United States, Canada
Becton, Dickinson and Company

Completed

Three-day, In-clinic Evaluation of the BD 2nd Generation Continuous Glucose Sensor Device in Type 1 Diabetics

Diabetes

Canada
Becton, Dickinson and Company

Completed

Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth

Preoperative Skin Preparation

United States
Becton, Dickinson and Company

Completed

Efficiency, and Emergency Department Nurse Preference Between 2 Methods of Visualization: A Pilot Study

Catheter Related Complication

United States
Becton, Dickinson and Company

Completed

Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens

Uterine Cervical Neoplasms

United States
Becton, Dickinson and Company

Terminated

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Uterine Cervical Neoplasm

United States, Canada
Becton, Dickinson and Company

Withdrawn

The PSIQS Study - User Experience With Pro-Set

Diabetes Mellitus, Type 1
Becton, Dickinson and Company

Completed

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Becton, Dickinson and Company

Completed

Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating

Diabetes Mellitus, Type 1

Germany
Weill Medical College of Cornell University
Becton, Dickinson and Company

Suspended

A Pilot Study to Evaluate PureWick for Nocturia

Nocturia

United States
University of Oxford
Beckton Dickinson

Recruiting

Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention (PROSPECT)

Pneumothorax | Pleural Diseases | Pleural Neoplasms | Pleural Effusion, Malignant | Pleural Effusion | Procedural Complication | Pleural Infection | Pleural Mesothelioma | Complications, Pulmonary | Pleural Metastases

United Kingdom
Becton, Dickinson and Company
Cromsource

Completed

Prospective Clinical Evaluation of BD Spinal Needles

Analgesia | Anesthesia

Germany, Austria, Spain, Finland, Switzerland
Becton, Dickinson and Company
Medtronic

Completed

BD FlowSmart™ Subcutaneous Insulin Infusion Set User Preference and Claims Study

Type 1 Diabetes Mellitus

United States

Clinical Trials Sponsored by Dickinson College

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations